Riber S.A. Stocks

11.28Last Updated 13.04.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

€ 278.26M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
News
11.28
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Riber S.A. offers molecular beam epitaxy (MBE) products and services for the semiconductor industry. The company provides epitaxy MBE products and services. It also offers MBE systems comprising of research and pilot production system, and solution for compound semiconductor passivation. In addition, the company provides MBE sources consisting of effusion cells, gas sources, resistive cell, and valved cracker sources, as well as MBE heaters and manipulators. Further, the company offers MBE accessories and services for PID loops, valve controllers, and other MBE software, as well as provides OEM components and systems consisting of point, valved, and linear sources; and process controllers. Additionally, it provides process control software. It serves power, lasers, IR detectors, display, passivation, materials, solar, and OEM applications. Riber S.A. was founded in 1964 and is headquartered in Bezons, France.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'expensive' on E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of ALRIB.PA is 5.9 and suggests 50% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks